Merck & Co Inc said on Thursday it agreed to acquire privately held VelosBio for $2.75 billion in cash, in a move that will help it strengthen its cancer drug portfolio.

Families from a Catholic high school in St. Louis have hired attorneys after police pepper-sprayed players following a game in Massillon last week.

Families accused police of targeting their players, saying police didn't pepper-spray any of the Ohio players.

SunTx-backed Suncrete to list on the NYSE via merger with SPAC Haymaker. Suncrete, a portfolio company of SunTx Capital Partners, is planning on trading on the New York Stock Exchange through a ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal ...

IonQ (NYSE: IONQ), a leading quantum company, today announced the pricing of a $2.0 billion equity offering consisting of ...

On September 29, 2025, Harkness Capital Partners ("Harkness" or "HCP"), completed an investment in Premier Fence, LLC ("Premier" or the "Company"), a leading provider of installation, repair, and ...

Harkness Capital Partners has made an investment in Premier Fence, a Canton, Massachusetts-based provider of installation, repair, and maintenance of fencing, guardrails, and gates/access controls.

South Korea-based conglomerate SK Group will take a 9.9% stake worth $1.5 billion in hydrogen fuel cell maker Plug Power Inc (PLUG.O) and form a joint venture to help provide hydrogen fuel cell ...

Detailed price information for Akero Therapeutics Inc (AKRO-Q) from The Globe and Mail including charting and trades.

Spirit Aviation Holdings, Inc., parent company of Spirit Airlines, LLC ("Spirit" or the "Company"), today announced it has received approval from the U.S. Bankruptcy Court for the Southern District of ...

Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseasesTransaction further ...